IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,800 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $6,697,000 | 0.99% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $939,000 | 0.34% |
| Winning Points Advisors, LLC | 43,958 | $428,000 | 0.31% |
| HARBOURVEST PARTNERS LLC | 335,709 | $3,270,000 | 0.31% |
| Clearwater Capital Advisors, LLC | 147,891 | $1,440,000 | 0.17% |
| SHEETS SMITH WEALTH MANAGEMENT | 121,923 | $1,188,000 | 0.16% |
| Jump Financial, LLC | 129,600 | $1,262,000 | 0.09% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 75,022 | $731,000 | 0.09% |
| ClariVest Asset Management LLC | 206,332 | $2,010,000 | 0.06% |
| Virtus ETF Advisers LLC | 14,244 | $139,000 | 0.06% |